Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
10 participants
INTERVENTIONAL
2017-01-01
2019-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Randomized Controlled Trial to Evaluate the Safety and Efficacy of Acetaminophen in Preterm Infants Used in Combination With Ibuprofen for Closure of the Ductus Arteriosus
NCT03701074
Combination of Acetaminophen and Ibuprofen in the Management of Patent Ductus Arteriosus
NCT03103022
Addition of Acetaminophen in Standard PDA Management
NCT04026464
Acetaminophen vs Indomethacin in Treating hsPDA
NCT03537144
Adding Paracetamol to Ibuprofen for Treatment of Patent Ductus Arteriosus in Preterm Infants
NCT02002741
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
acetaminophen
Group of patients randomized to receive acetaminophen to treat their PDA
Acetaminophen
infants receive acetaminophen for treatment of their PDA
ibuprofen
Group of patients randomized to receive ibuprofen to treat their PDA
Ibuprofen
infants receive ibuprofen, standard of care in our unit, for treatment of a PDA
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Acetaminophen
infants receive acetaminophen for treatment of their PDA
Ibuprofen
infants receive ibuprofen, standard of care in our unit, for treatment of a PDA
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* PDA requiring treatment
Exclusion Criteria
* congenital heart disease,
* genetic syndrome,
* NEC,
* pulmonary hypertension,
* hydrops,
* intestinal perforation,
* grade 3 or 4 IVH,
* serum creatinine \>1.5,
* previous treatment with a COX inhibitor.
1 Minute
2 Weeks
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Albany Medical College
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Kate Tauber
Assistant Professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Albany Medical Center Neonatal Intesive Care Unit
Albany, New York, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
4683
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.